Author

Chaoting Zhang

Peking University Cancer HospitalORCID 0000-0002-2094-9171Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Assay:multiome· 1 Organism:non-human primate· 1

Frequent Co-Authors

Juntao YuiD· 1 shared Qiang ChengiD· 1 shared Qiu WangiD· 1 shared Quan LiiD· 1 shared Rongkuan HuiD· 1 shared Shenggen Luo· 1 shared Xi ZhangiD· 1 shared Xiaona WangiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Juntao YuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringBiomaterialsPeer-reviewedDec 24, 2024

Targeted LNPs deliver mRNA encoding IL-15 superagonists to balance efficacy and toxicity in cancer therapy

Juntao Yu, Quan Li, Chaoting Zhang…·Qiang Cheng

This study uses targeted mRNA-LNPs to deliver IL-15 superagonists, improving anti-tumor efficacy while reducing toxicity compared to existing therapies.

29 citations

non-human primatemultiome

𝕏 PostBluesky

BioinformaticsbioRxivPreprintJun 27, 2024

TCRfinder: Improved TCR virtual screening for novel antigenic peptides with tailored language models

Yang Li, Chaoting Zhang, Xi Zhang, Yang Zhang

TCRfinder improves TCR-peptide binding prediction using tailored language models, achieving higher accuracy than existing methods in identifying interacting TCRs and tumor neoantigens.

4 citations

deep learningdrug response / drug discovery

𝕏 PostBluesky